(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) rising 15.25% to €9.22 on Monday while BEL 20 rose 0.3% to €3,849.52.
NYXOAH’s last close was €8.00, 53.27% below its 52-week high of €17.12.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.22%.
Volatility
NYXOAH’s last week, last month’s, and last quarter’s current intraday variation average was 4.19%, 1.82%, and 2.32%.
NYXOAH’s highest amplitude of average volatility was 4.19% (last week), 2.94% (last month), and 2.32% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
NYXOAH’s EBITDA is -3.76.
Moving Average
NYXOAH’s value is way higher than its 50-day moving average of €5.66 and way above its 200-day moving average of €6.62.
Sales Growth
NYXOAH’s sales growth is 83.3% for the current quarter and 92.5% for the next.
More news about NYXOAH (NYXH.BR).
